English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [69]
News [229]
Articles [19]
Editorials [2]
Conferences [42]
elearning [2]
European Cancer Patient Coalition comments on EU's cancer beating plan
European Cancer Patient Coalition comments on EU's cancer beating plan
Expanded PET imaging time window adds flexibility for neuroendocrine tumour patients
Expanded PET imaging time window adds flexibility for neuroendocrine tumour patients
European Association of Cancer Research calls for award nominations
European Association of Cancer Research calls for award nominations
FDA approves pralsetinib for RET-altered thyroid cancers
FDA approves pralsetinib for RET-altered thyroid cancers
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
The European code of cancer practice: championing the rights of cancer patients across Europe
The European code of cancer practice: championing the rights of cancer patients across Europe
Free from cancer: Achieving quality of life for all cancer patients and survivors
Free from cancer: Achieving quality of life for all cancer patients and survivors
Addressing the disparities in global cancer care
Addressing the disparities in global cancer care
FDA approves companion diagnostic test to identify NTRK fusions in solid tumours for vitrakvi
FDA approves companion diagnostic test to identify NTRK fusions in solid tumours for vitrakvi
UCalgary researchers discover new tactic to stop the growth of a deadly brain cancer
UCalgary researchers discover new tactic to stop the growth of a deadly brain cancer
<12345...23>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307